CTSO Message Board Post 19626966 | CytoSorbents Corporation
home / stock / ctso / ctso message board
ldickey
(investorshub)
Posted on: Jul/07/2023 02:53:18
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172285270
Extracorporeal hemoadsorption therapy as a potential therapeutic option
News, Short Squeeze, Breakout and More Instantly...
-
The De Novo medical device application for DrugSorb™-ATR is eligible for FDA priority review as an FDA Breakthrough Designated Device for this indication The Health Canada Medical Device License application is ready for submission, pending the expected receipt of Medical Device...
-
PRINCETON, N.J., Aug. 27, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today announced t...
-
PRINCETON, N.J., Aug. 16, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today announced that it g...